York, in the matter of Exactech, Inc (No 2)

Link copied
Case Copied 19 min read

FEDERAL COURT OF AUSTRALIA

York, in the matter of Exactech, Inc (No 2) [2025] FCA 73

File number(s): NSD 1842 of 2024
Judgment of: HALLEY J
Date of judgment: 6 February 2025
Date of publication of reasons 12 February 2025
Catchwords:

 BANKRUPTCY AND INSOLVENCY – application for recognition of United States bankruptcy proceeding as a “foreign main proceeding” pursuant to the Cross-Border Insolvency Act 2008 (Cth) and the Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law (Model Law) – whether proceeding a “foreign proceeding” and a “foreign main proceeding” pursuant to art 17 of the Model Law – orders made

PRACTICE AND PROCEDURE – application to dispense with r 15A.7 of the Federal Court (Corporations) Rules 2000 (Cth) – where plaintiffs seek to modify notification regime – where number of interested affected persons yet to be ascertained – orders made

Legislation:

Corporations Act 2001 (Cth) Pt 5.3A

Cross‑Border Insolvency Act 2008 (Cth) Sch 1, Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law (UNCITRAL) arts 2, 15, 16, 17

Federal Court (Corporations) Rules 2000 (Cth) Div 15A, rr 15A.3, 15A.7

Cases cited:

Akers v Deputy Commission of Taxation (2014) 223 FCR 8; [2014] FCAFC 57

Aquino (Trustee), Re Mcgowan (Bankrupt) v Mcgowan [2020] FCA 221

Bradley, in the matter of Astora Women’s Health, LLC v Astora Women’s Health, LLC (No 2) [2022] FCA 1268

Kapila, in the matter of Edelsten (2014) 320 ALR 506; [2014] FCA 1112

Moore as Debtor-in-Possession of Australian Equity Investors v Australian Equity Investors [2012] FCA 1002

Re Senvion GmbH (No 2) (2019) 140 ACSR 20; [2019] FCA 1732

Tai-Soo Suk v Hanjin Shipping Co Ltd [2016] FCA 1404

York, in the matter of Exactech, Inc [2024] FCA 1522

Young, Jr, in the matter of Buccaneer Energy Limited v Buccaneer Energy Limited [2014] FCA 711

Division: General Division
Registry: New South Wales
National Practice Area: Commercial and Corporations
Sub-area: Corporations and Corporate Insolvency
Number of paragraphs: 55
Date of hearing: 6 February 2025
Counsel for the Plaintiff: Ms E L Beechey
Solicitor for the Plaintiff: Clayton Utz
Counsel for the Defendant: The Defendant did not appear
Counsel for the Interested Party  Mr M Robinson
Solicitor for the Interested Party  Gerard Malouf & Partners

ORDERS

NSD 1842 of 2024

IN THE MATTER OF EXACTECH, INC.

BETWEEN:

JESSE YORK IN HIS CAPACITY AS FOREIGN REPRESENTATIVE OF EXACTECH, INC.

Plaintiff

AND:

EXACTECH, INC.

Defendant

ORDER MADE BY:

HALLEY J

DATE OF ORDER:

6 FEBRUARY 2025

THE COURT ORDERS THAT:

1.Pursuant to art 17(1) of the Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law (Model Law) and s 6 of the Cross-Border Insolvency Act 2008 (Cth) (Cross-Border Insolvency Act), that Case No. 24-12441 (which is being jointly administered for procedural purposes only with Docket No. 24-12438, 24-12439, 24-12440 and 24-12442) filed by Exactech, Inc (Exactech) in the United States Bankruptcy Court for…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read York, in the matter of Exactech, Inc (No 2) and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2025] FCA 73
Decision Date

CaseChat Overview and Summary

The case of York, in the matter of Exactech, Inc (No 2) before the Federal Court of Australia involved an application by Jesse York, the Chief Restructuring Officer of Exactech, a United States-based manufacturer of orthopaedic implant devices, to recognise the United States bankruptcy proceedings of Exactech as a "foreign main proceeding" under the Cross-Border Insolvency Act 2008 (Cth) and the Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law. Exactech, which operates globally, had filed for bankruptcy in the United States Bankruptcy Court for the District of Delaware following significant litigation relating to product recalls and false claims allegations. The court was tasked with determining whether the United States bankruptcy proceeding qualified as a "foreign main proceeding" and whether certain notification requirements could be modified.

The court considered whether the United States bankruptcy proceeding met the criteria of being a "foreign main proceeding" under the Model Law, which requires that the proceeding be a collective proceeding involving reorganisation, administration, or liquidation of an estate and be open and governed by the laws of a foreign country. The court also evaluated the application to dispense with certain notification requirements under the Federal Court (Corporations) Rules 2000 (Cth) due to the difficulty in identifying all affected parties at that stage. The Chief Restructuring Officer argued that the usual notification process was impractical given the large and potentially unknown number of affected parties.

The Federal Court held that the United States bankruptcy proceeding qualified as a "foreign main proceeding" under the Model Law, as it was a collective proceeding open and governed by United States law, involving the reorganisation of Exactech’s estate. The court further determined that the notification requirements could be modified to allow for a more efficient and practical approach to notifying affected parties, given the uncertainty regarding the total number of individuals and entities impacted. The court issued orders recognising the United States bankruptcy proceeding as a foreign main proceeding, recognising Jesse York as the foreign representative, and modifying the notification regime to suit the specific circumstances of the case.

The final orders included recognising the United States bankruptcy proceeding as a foreign main proceeding, establishing the scope of any stay or suspension in accordance with Australian law, and modifying the notification requirements to allow for targeted distribution to known affected parties and their representatives. Any party aggrieved by these orders had the right to apply to vary or set aside them within five business days.

Orders

Orders of the court

1. Pursuant to art 17(1) of the Model Law on Cross-Border Insolvency of the United Nations Commission on International Trade Law (Model Law) and s 6 of the Cross-Border Insolvency Act 2008 (Cth) (Cross-Border Insolvency Act), that Case No. 24-12441 (which is being jointly administered for procedural purposes only with Docket No. 24-12438, 24-12439, 24-12440 and 24-12442) filed by Exactech, Inc (Exactech) in the United States Bankruptcy Court for the District of Delaware (Exactech Chapter 11 Case) be recognised as a foreign proceeding.

2. Pursuant to art 17(2)(a) of the Model Law, the Exactech Chapter 11 Case be recognised as a foreign main proceeding within the meaning of art 2(b) of the Model Law.

3. The plaintiff, Jesse York, be recognised as a foreign representative of Exactech within the meaning of art 2(d) of the Model Law.

4. For the purposes of art 20(2) of the Model Law and s 16 of the Cross-Border Insolvency Act, the scope, and the modification or termination, of the stay and suspension referred to in art 20(1) of the Model Law with respect to Exactech be the same as would apply if the stay or suspension arose under part 5.3A in Chapter 5 of the Corporations Act 2001 (Cth) (Corporations Act), and as if:

(a) Part 5.3A of the Corporations Act applied to Exactech (as a company subject to administration under that Part); and

(b) references in part 5.3A of the Corporations Act to the consent of the company’s administrators are taken to be references to the consent of the plaintiff as foreign representative.

5. The requirements of r 15A.7(1) of the Federal Court (Corporations) Rules 2000 (Cth) be dispensed with and in lieu thereof the plaintiff distribute the form appearing in the Schedule to these Orders (Notice) as follows:

(a) within 15 business days of the making of these orders, the plaintiff give the Notice to the applicant in proceeding NSD 1224 of 2024 by sending a copy of the Notice to the applicants’ solicitors, Gerard Malouf & Partners, once by way of email to exactechclaim@gmp.net.au and once by ordinary post;

(b) within 15 business days of the making of these orders, the plaintiff to give the Notice to the persons identified in paragraphs 30 and 42 of the Affidavit of Jesse York affirmed on 19 December 2024 and to the persons identified in paragraph 10 of the Affidavit of Suami Campos affirmed on 5 February 2025 by sending the Notice to the postal address by ordinary post and to last known email address (where known) of each of the persons, or to their solicitors where legally represented once by way of email and once by ordinary post.

6. Any party affected by these orders is at liberty to apply upon 5 business days’ notice to vary or set aside these orders.

Notice

[The order entered is available on the Commonwealth Courts Portal, which attaches the Notice]

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Rule 15A.3(2)(b) of the Corporations Rules requires that the debtor, Exactech, be the defendant.B. BACKGROUND I set out the background of this proceeding in York, in the matter of Exactech, Inc [2024] FCA 1522 at [5]-[14] and for convenience repeat it below. Mr York is the Chief Restructuring Officer of Exactech. Exactech is a United States company incorporated and headquartered in Florida. It is relevantly a manufacturer and developer of orthopaedic implant devices. Its products relevantly include hip implants, knee implants, and shoulder glenoids and liners. Exactech distributes its products to markets throughout the United States, Europe, South America, Asia, and Australia. Exactech is part of the Exactech Group, the ultimate parent company of which is Osteon Holdings (Osteon), Inc. Exactech is the main operating company for the Exactech Group’s United States’ operations. Since 2021, various Exactech Group companies have faced significant litigation stemming from certain product recalls. In particular, Exactech, in coordination with the United States Food and Drug Administration, voluntarily recalled certain knee, hip and shoulder components which had been distributed in non-conforming packaging. More than 2,585 patients have filed lawsuits in multiple Federal, State, and non-United States courts alleging damages relating primarily to the non-conforming packaging and resulting recalls. Separately, Exactech has been defending “qui tam claims”, being claims brought by individuals on behalf of a State or the Federal government of the United States. These claims were originally filed in 2018 in the Northern District of Alabama, which, together with a separate investigation initiated in 2023, involve allegations that Exactech’s sale of certain knee devices violated the False Claims Act and similar State statutes. As at 29 October 2024, Exactech had approximately $606 million in total assets and approximately $485 million in total liabilities, not including any liabilities that Exactech may have as a result of the pending litigation or other potential litigation. In Australia, Exactech’s products are distributed by Exactech Australia. Exactech Australia is an indirect subsidiary of Exactech. Exactech Australia is not in any form of external administration. In the period between 21 August 2021 and 7 March 2024, Exactech Australia, in consultation with the Australian Therapeutic Goods Administration, recalled knee, hip and shoulder components manufactured by Exactech and packaged in non-conforming packaging that Exactech Australia had distributed in Australia. On 29 October 2024, Exactech, Osteon and three other companies in the Exactech Group each filed voluntary petitions in the US Bankruptcy Court to commence bankruptcy proceedings under Chapter 11 of Title 11 of the United States Bankruptcy Code. The US Bankruptcy Court ordered that the five Chapter 11 proceedings be consolidated for administrative purposes under Case No. 24-12441. C. COMPLIANCE WITH NOTIFICATION ORDERS AND SERVICE REQUIREMENTS

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established

On 23 December 2024, I made an order granting an interim stay pursuant to art 19 of the Model Law, pending final determination of the Model Law Application on 6 February 2025. I also made orders providing for directions for notifying potential creditors and other persons who may have an interest in the Model Law Application, in place of the requirements for notification set out in r 15A.6 and r 15A.7 of the Federal Court (Corporations) Rules 2000 (Cth) (Corporations Rules). Ms E L Beechey of counsel appeared for Mr York. Mr York relies on the following evidence:(a)the affidavit that he affirmed on 19 December 2024 (York Affidavit) together with Exhibit JY-1 to that affidavit; and (b)the affidavits of Suami Campos, a solicitor employed by Clayton Utz who has carriage of the matter for Mr York, affirmed on 5 February 2025 and 6 February 2025. Simon Harrold, the lead applicant in the class action commenced against Exactech Australia Pty Ltd (Exactech Australia) and Exactech in this Court in September 2024, being proceeding NSD 1224 of 2024 (Class Action), sought and was granted leave to appear at the hearing today as an interested party. Mr M Robinson of counsel appeared for Mr Harrold. Mr Harrold relies on the affidavit sworn on 6 February 2025 by Diane Gail Chapman, a special counsel employed by the solicitors for Mr Harrold in the Class Action. Rule 15A.3(2)(b) of the Corporations Rules requires that the debtor, Exactech, be the defendant.B. BACKGROUND I set out the background of this proceeding in York, in the matter of Exactech, Inc [2024] FCA 1522 at [5]-[14] and for convenience repeat it below. Mr York is the Chief Restructuring Officer of Exactech. Exactech is a United States company incorporated and headquartered in Florida. It is relevantly a manufacturer and developer of orthopaedic implant devices. Its products relevantly include hip implants, knee implants, and shoulder glenoids and liners. Exactech distributes its products to markets throughout the United States, Europe, South America, Asia, and Australia. Exactech is part of the Exactech Group, the ultimate parent company of which is Osteon Holdings (Osteon), Inc. Exactech is the main operating company for the Exactech Group’s United States’ operations. Since 2021, various Exactech Group companies have faced significant litigation stemming from certain product recalls. In particular, Exactech, in coordination with the United States Food and Drug Administration, voluntarily recalled certain knee, hip and shoulder components which had been distributed in non-conforming packaging. More than 2,585 patients have filed lawsuits in multiple Federal, State, and non-United States courts alleging damages relating primarily to the non-conforming packaging and resulting recalls. Separately, Exactech has been defending “qui tam claims”, being claims brought by individuals on behalf of a State or the Federal government of the United States. These claims were originally filed in 2018 in the Northern District of Alabama, which, together with a separate investigation initiated in 2023, involve allegations that Exactech’s sale of certain knee devices violated the False Claims Act and similar State statutes.